| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $130.5M | +52.4% |
| SG&A Expense | $75.5M | +23.3% |
| Operating Income | -$206.1M | -40.3% |
| Net Income | -$188.9M | -32.9% |
| EPS (Basic) | -$2.37 | -9.2% |
| EPS (Diluted) | -$2.37 | -9.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $230.8M | +170.7% |
| Short-term Investments | $135.6M | -47.3% |
| Current Assets | $375.3M | +7.9% |
| Total Assets | $376.0M | +7.7% |
| Current Liabilities | $29.5M | +77.6% |
| Total Liabilities | $29.5M | +73.3% |
| Stockholders' Equity | $346.5M | +4.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$146.9M | -33.7% |
| Capital Expenditures | $224K | +761.5% |
| Investing Cash Flow | $128.4M | +150.3% |
| Financing Cash Flow | $164.0M | -1.1% |
| Free Cash Flow | -$147.1M | -33.8% |